Colorcon Film Coating Leadership

New OneLock Closure Designed for Simple Integration into Existing Production Lines

In 1980, The Empire Strikes Back, part of the popular Star Wars franchise, dominated the box office. Former actor, Ronald Reagan, took office as the 40th President of the United States. And during that same year, a quieter—but we would argue, equally transformative—moment unfolded in pharmaceutical manufacturing: Opadry®, the first-of-its-kind complete film coating system, entered the market. Opadry was the original fully formulated film coating system for solid oral dosage forms—marking a new era of reliability, consistency and simplicity for pharmaceutical companies worldwide.

OneLock™ is an all‑in‑one integrated closure system designed to simplify packaging while delivering reliable moisture protection, safety features, and regulatory confidence across global markets.

On August 6th, 2025, the European Commission published a Staff Working Document reaffirming its position: Titanium dioxide remains approved for use as a colorant in medicinal products under Regulation (EU) 2022/63. This decision follows the European Medicines Agency’s (EMA) April 2024 review.

Phytolon leverages bio-production and precision fermentation to create natural food colors

The Johor plant is Colorcon’s 7th major film coating plant and their 16th manufacturing facility worldwide.

Harleysville, Pennsylvania, USA, 23 January 2024. 

Colorcon, a world leader in the development and supply of film coating systems, specialty excipients, and functional packaging for the healthcare industries, announces the launch of a new Opadry® titanium dioxide (TiO2)-free film coating system for pharmaceutical tablets.

Harleysville, Pennsylvania, USA, 2nd March 2023, Colorcon, Inc., a global leader in pharmaceutical film coatings and specialty excipients, today announces that it has completed the acquisition of Airnov Healthcare Packaging, Inc. from Arsenal Capital Partners.